Literature DB >> 25438683

Diabetes mellitus is associated with gastroesophageal variceal bleeding in cirrhotic patients.

Chun-Hsun Yang1, Yi-Chun Chiu2, Chih-Hung Chen3, Chien-Hung Chen2, Ming-Chao Tsai2, Seng-Kee Chuah2, Chih-Hsiung Lee3, Tsung-Hui Hu2, Chao-Hung Hung4.   

Abstract

Diabetes mellitus (DM) has been reported to increase the risk of complications of liver cirrhosis of any etiology and subsequent survival. However, the impact of DM on the development of gastroesophageal variceal bleeding (GEVB) remains unclear. We aimed to elucidate whether DM is an independent risk factor for GEVB among cirrhotic patients. A total of 146 consecutive patients with liver cirrhosis (Child-Pugh Class A, n = 75; Class B, n = 40; and Class C, n = 31) were prospectively enrolled. Data on clinical and biochemical characteristics and history of ascites, GEVB, hepatic encephalopathy, and spontaneous bacterial peritonitis were retrospectively reviewed. Of these 146 patients, 37 (25%) had DM. Patients with DM had significantly higher ratio of Child-Pugh Class B/C (p = 0.043), renal insufficiency (p = 0.002), and history of GEVB (p = 0.006) compared with non-DM patients. GEVB was associated with Child-Pugh Class B/C (p = 0.001), ascites (p = 0.002), hepatic encephalopathy (p = 0.023), and low platelet counts (p < 0.001). Based on stepwise multiple logistic regression analysis, Child-Pugh class B/C [odds ratio (OR) = 4.90, p = 0.003] and DM (OR = 2.99, p = 0.022) were identified as independent predictors of GEVB. In the subgroup analysis, DM significantly correlated with GEVB in patients with Child-Pugh Class A (p = 0.042), but not in patients with Child-Pugh Class B/C (p = 0.128). DM is independently associated with GEVB in cirrhotic patients, especially in those with Child-Pugh Class A.
Copyright © 2014. Published by Elsevier Taiwan.

Entities:  

Keywords:  Cirrhosis; Diabetes mellitus; Variceal bleeding; Varices

Mesh:

Year:  2014        PMID: 25438683     DOI: 10.1016/j.kjms.2014.06.002

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  6 in total

1.  Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.

Authors:  Tsai-Ling Liu; Justin Trogdon; Morris Weinberger; Bruce Fried; A Sidney Barritt
Journal:  Dig Dis Sci       Date:  2016-08-01       Impact factor: 3.199

2.  Effect of coexisting diabetes mellitus and chronic kidney disease on mortality of cirrhotic patients with esophageal variceal bleeding.

Authors:  Chia-Chi Lung; Zhi-Hong Jian; Jing-Yang Huang; Oswald Ndi Nfor
Journal:  BMC Gastroenterol       Date:  2016-02-29       Impact factor: 3.067

Review 3.  Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives.

Authors:  Diego García-Compeán; Emanuela Orsi; Ramesh Kumar; Felix Gundling; Tsutomu Nishida; Jesús Zacarías Villarreal-Pérez; Ángel N Del Cueto-Aguilera; José A González-González; Giuseppe Pugliese
Journal:  World J Gastroenterol       Date:  2022-02-28       Impact factor: 5.742

Review 4.  Hepatogenous diabetes: Knowledge, evidence, and skepticism.

Authors:  Ramesh Kumar; Diego García-Compeán; Tanmoy Maji
Journal:  World J Hepatol       Date:  2022-07-27

5.  Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis.

Authors:  Sang Bong Ahn; Elizabeth E Powell; Anthony Russell; Gunter Hartel; Katharine M Irvine; Chris Moser; Patricia C Valery
Journal:  Hepatol Commun       Date:  2020-06-30

6.  Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy.

Authors:  Qun Zhang; Fangyuan Gao; Xue Yang; Ying Hu; Yao Liu; Yixin Hou; Yuxin Li; Bingbing Zhu; Shuaishuai Niu; Yunyi Huang; Xianbo Wang
Journal:  Med Sci Monit       Date:  2020-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.